CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | photosynthetic electron-transport chain inhibitor |
|
Accession: | CHEBI:26087
|
browse the term
|
|
|
|
G |
A3galt2 |
alpha 1,3-galactosyltransferase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of A3GALT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641
|
|
G |
Aagab |
alpha- and gamma-adaptin binding protein |
increases expression |
EXP |
Diuron results in increased expression of AAGAB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:64,083,343...64,121,903
Ensembl chr 8:64,083,380...64,121,900
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ABCC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
decreases expression |
EXP |
Diuron results in decreased expression of ABCC5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abhd12 |
abhydrolase domain containing 12, lysophospholipase |
increases expression |
EXP |
Diuron results in increased expression of ABHD12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:139,659,315...139,719,529
Ensembl chr 3:139,659,317...139,719,564
|
|
G |
Abhd17c |
abhydrolase domain containing 17C, depalmitoylase |
increases expression |
EXP |
Diuron results in increased expression of ABHD17C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:138,084,632...138,125,595
Ensembl chr 1:138,084,634...138,125,595
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
EXP |
Diuron results in increased expression of ABHD4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ABI3BP mRNA Diuron results in decreased expression of ABI3BP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Ablim1 |
actin-binding LIM protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ABLIM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:256,084,293...256,372,075
Ensembl chr 1:256,084,297...256,371,969
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
increases expression |
EXP |
Diuron results in increased expression of ACAA1A mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:119,079,401...119,088,624
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
increases expression |
EXP |
Diuron results in increased expression of ACAD11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
increases expression |
EXP |
Diuron results in increased expression of ACAD9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
increases expression |
EXP |
Diuron results in increased expression of ACADL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACAT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
increases expression |
EXP |
Diuron results in increased expression of ACBD4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACER2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ACKR3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Ackr4 |
atypical chemokine receptor 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ACKR4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617
|
|
G |
Aco2 |
aconitase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACO2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
EXP |
Diuron results in increased expression of ACOT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
EXP |
Diuron results in increased expression of ACOT2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
Diuron results in increased expression of ACOX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:101,406,197...101,431,242
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
increases expression |
EXP |
Diuron results in increased expression of ACP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSL1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSL4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ACSS2 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
EXP |
Diuron results in decreased expression of ACTA1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:51,883,713...51,886,725
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
EXP |
Diuron results in increased expression of ACTA2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ACTC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of ACTG2 mRNA Diuron results in increased expression of ACTG2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
EXP |
Diuron results in increased expression of ACTN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Actr3 |
actin related protein 3 |
increases expression |
EXP |
Diuron results in increased expression of ACTR3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Actr3b |
actin related protein 3B |
decreases expression |
EXP |
Diuron results in decreased expression of ACTR3B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
Diuron metabolite results in increased expression of ACVR1C mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
increases expression |
EXP |
Diuron results in increased expression of ADAM10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAM33 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:118,262,395...118,283,461
Ensembl chr 3:118,271,029...118,283,461
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
Diuron results in increased expression of ADAM8 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ADAMTS9 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ADAMTSL4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adamtsl5 |
ADAMTS-like 5 |
increases expression |
EXP |
Diuron results in increased expression of ADAMTSL5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:9,362,623...9,371,248
Ensembl chr 7:9,363,237...9,370,285
|
|
G |
Adcy6 |
adenylate cyclase 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ADCY6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Add3 |
adducin 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ADD3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
EXP |
Diuron results in increased expression of ADGRF4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
increases expression |
EXP |
Diuron results in increased expression of ADGRL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
EXP |
Diuron results in increased expression of ADH7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adi1 |
acireductone dioxygenase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ADI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression |
EXP |
Diuron results in decreased expression of ADIPOQ mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Aebp1 |
AE binding protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AEBP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Afdn |
afadin, adherens junction formation factor |
decreases expression |
EXP |
Diuron results in decreased expression of AFDN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:53,884,711...54,034,216
Ensembl chr 1:53,905,373...54,034,216
|
|
G |
Agmo |
alkylglycerol monooxygenase |
increases expression |
EXP |
Diuron results in increased expression of AGMO mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AGPAT3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
Diuron results in decreased expression of AGT mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
Diuron results in decreased expression of AGTR1A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
EXP |
Diuron results in decreased expression of AHNAK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects binding multiple interactions |
ISO EXP |
Diuron binds to AHR protein Diuron binds to and results in increased activity of AHR protein Diuron binds to and results in increased activity of AHR protein; Diuron inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:16705413 PMID:16788953 PMID:18835618 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression decreases expression |
EXP |
Diuron results in increased expression of AHRR mRNA Diuron results in decreased expression of AHRR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AIF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Ajuba |
ajuba LIM protein |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of AJUBA mRNA Diuron metabolite results in decreased expression of AJUBA mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
Diuron results in increased expression of AKAP12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
decreases expression |
EXP |
Diuron results in decreased expression of AKAP9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
EXP |
Diuron results in increased expression of AKR1B1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
EXP |
Diuron results in increased expression of AKR1B8 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of AKR1C1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of AKR1C2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of AKR1C3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
Diuron results in increased expression of AKR7A3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
EXP |
Diuron results in decreased expression of ALCAM mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
Diuron results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
EXP |
Diuron metabolite results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ALDH3A1 mRNA Diuron metabolite results in decreased expression of ALDH3A1 mRNA; Diuron results in decreased expression of ALDH3A1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
EXP |
Diuron results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
increases expression |
EXP |
Diuron results in increased expression of ALG5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:138,936,998...138,951,228
Ensembl chr 2:138,936,993...138,951,216
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
decreases expression |
EXP |
Diuron results in decreased expression of ALOX12 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ALPL mRNA Diuron results in decreased expression of ALPL mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amotl2 |
angiomotin like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
EXP |
Diuron results in increased expression of AMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Andpro |
androgen regulated protein |
increases expression |
EXP |
Diuron results in increased expression of ANDPRO mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
|
|
G |
Angpt4 |
angiopoietin 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANGPT4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ANK2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
increases expression |
EXP |
Diuron results in increased expression of ANKRD34B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:23,651,083...23,668,041
Ensembl chr 2:23,651,474...23,668,030
|
|
G |
Ankrd50 |
ankyrin repeat domain containing 50 |
increases expression |
EXP |
Diuron results in increased expression of ANKRD50 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:121,466,275...121,500,758
Ensembl chr 2:121,468,573...121,500,752
|
|
G |
Ankrd6 |
ankyrin repeat domain 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ANKRD6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090
|
|
G |
Anks1a |
ankyrin repeat and sterile alpha motif domain containing 1A |
decreases expression |
EXP |
Diuron results in decreased expression of ANKS1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:5,963,658...6,117,139
Ensembl chr20:5,963,678...6,117,148
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
Diuron results in decreased expression of ANLN mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ANP32E mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
decreases expression |
EXP |
Diuron results in decreased expression of ANPEP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
increases expression decreases expression |
ISO EXP |
Diuron metabolite results in increased expression of ANTXR2 mRNA Diuron results in decreased expression of ANTXR2 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr14:11,542,266...11,682,112
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa4 |
annexin A4 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
EXP |
Diuron results in increased expression of ANXA6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Anxa7 |
annexin A7 |
increases expression |
EXP |
Diuron results in increased expression of ANXA7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Anxa9 |
annexin A9 |
decreases expression |
EXP |
Diuron results in decreased expression of ANXA9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of AOC3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Aox1 |
aldehyde oxidase 1 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of AOX1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
decreases expression |
EXP |
Diuron results in decreased expression of AP1B1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AP1S2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
decreases expression |
EXP |
Diuron results in decreased expression of AP2A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:196,652,315...196,725,609
Ensembl chr 1:196,652,337...196,725,603
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
decreases expression |
EXP |
Diuron results in decreased expression of APBB1IP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
increases expression |
EXP |
Diuron results in increased expression of APBB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
decreases expression |
EXP |
Diuron results in decreased expression of APOBEC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
|
|
G |
Apod |
apolipoprotein D |
decreases expression |
EXP |
Diuron results in decreased expression of APOD mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
decreases expression |
EXP |
Diuron results in decreased expression of APOE mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
EXP |
Diuron results in decreased expression of APP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
EXP |
Diuron results in increased expression of AQP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp7 |
aquaporin 7 |
decreases expression |
EXP |
Diuron results in decreased expression of AQP7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO EXP |
Dihydrotestosterone inhibits the reaction [Diuron results in increased activity of AR protein]; Diuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Diuron inhibits the reaction [Metribolone results in increased activity of AR protein] Diuron results in decreased expression of AR mRNA |
CTD |
PMID:15064155 PMID:18324785 PMID:25152437 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
increases expression |
EXP |
Diuron results in increased expression of ARAP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555
|
|
G |
Areg |
amphiregulin |
decreases expression |
EXP |
Diuron results in decreased expression of AREG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arf6 |
ADP-ribosylation factor 6 |
increases expression |
EXP |
Diuron results in increased expression of ARF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ARG1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap20 |
Rho GTPase activating protein 20 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGAP20 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:52,074,472...52,155,739
Ensembl chr 8:52,074,158...52,155,739
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
increases expression |
EXP |
Diuron results in increased expression of ARHGAP24 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:6,800,631...7,184,001
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arhgef18 |
Rho/Rac guanine nucleotide exchange factor 18 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF18 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:1,395,035...1,503,081
Ensembl chr12:1,395,088...1,503,081
|
|
G |
Arhgef25 |
Rho guanine nucleotide exchange factor 25 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF25 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:63,005,938...63,013,325
Ensembl chr 7:63,005,940...63,013,719
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
increases expression |
EXP |
Diuron results in increased expression of ARHGEF26 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819
|
|
G |
Arhgef40 |
Rho guanine nucleotide exchange factor 40 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGEF40 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:24,672,645...24,696,510
Ensembl chr15:24,672,763...24,696,510
|
|
G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ARHGEF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
|
|
G |
Arl11 |
ADP-ribosylation factor like GTPase 11 |
decreases expression |
EXP |
Diuron results in decreased expression of ARL11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:35,483,330...35,485,579
Ensembl chr15:35,480,018...35,496,596
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
decreases expression |
EXP |
Diuron results in decreased expression of ARL4D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
increases expression |
EXP |
Diuron results in increased expression of ARPC1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
increases expression |
EXP |
Diuron results in increased expression of ARPC2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:11,137,443...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ART3 mRNA Diuron results in decreased expression of ART3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
|
|
G |
Asb8 |
ankyrin repeat and SOCS box-containing 8 |
increases expression |
EXP |
Diuron results in increased expression of ASB8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:129,261,397...129,297,492
Ensembl chr 7:129,261,397...129,297,485
|
|
G |
Ascl3 |
achaete-scute family bHLH transcription factor 3 |
increases expression |
EXP |
Diuron results in increased expression of ASCL3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:163,755,306...163,755,951
Ensembl chr 1:163,754,956...163,759,682
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ASGR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Ash1l |
ASH1 like histone lysine methyltransferase |
decreases expression |
EXP |
Diuron results in decreased expression of ASH1L mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
|
|
G |
Ash2l |
ASH2 like histone lysine methyltransferase complex subunit |
increases expression |
EXP |
Diuron results in increased expression of ASH2L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:66,242,205...66,264,064
Ensembl chr16:66,242,212...66,264,061
|
|
G |
Aspn |
asporin |
decreases expression |
EXP |
Diuron results in decreased expression of ASPN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of ASS1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ATF3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atl3 |
atlastin GTPase 3 |
increases expression |
EXP |
Diuron results in increased expression of ATL3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:204,680,958...204,727,360
Ensembl chr 1:204,680,968...204,723,354
|
|
G |
Atosa |
atos homolog A |
increases expression |
EXP |
Diuron results in increased expression of ATOSA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
EXP |
Diuron results in increased expression of ATOX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
increases expression |
EXP |
Diuron results in increased expression of ATP10D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp1b3 |
ATPase Na+/K+ transporting subunit beta 3 |
increases expression |
EXP |
Diuron results in increased expression of ATP1B3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
|
|
G |
Atp23 |
ATP23 metallopeptidase and ATP synthase assembly factor homolog |
decreases expression |
EXP |
Diuron results in decreased expression of ATP23 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:62,714,752...62,729,893
Ensembl chr 7:62,714,785...62,729,862
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
EXP |
Diuron results in increased expression of ATP2A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
decreases expression |
EXP |
Diuron results in decreased expression of ATP5F1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
decreases expression |
EXP |
Diuron results in decreased expression of ATP5F1E mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ATP6V0D2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
Diuron results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
EXP |
Diuron results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression |
EXP |
Diuron results in decreased expression of ATRX mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn10 |
ataxin 10 |
increases expression |
EXP |
Diuron results in increased expression of ATXN10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
increases expression |
EXP |
Diuron results in increased expression of AUH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:12,329,522...12,424,896
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO EXP |
Diuron metabolite results in decreased expression of AXL mRNA Diuron results in decreased expression of AXL mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
EXP |
Diuron results in decreased expression of B2M mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of B3GALNT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
increases expression |
EXP |
Diuron results in increased expression of B4GALT6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:11,958,382...12,015,247
Ensembl chr18:11,958,390...12,015,247
|
|
G |
Bag1 |
BAG cochaperone 1 |
increases expression |
EXP |
Diuron results in increased expression of BAG1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
increases expression |
EXP |
Diuron results in increased expression of BAZ1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459
|
|
G |
Bbln |
bublin coiled coil protein |
increases expression |
EXP |
Diuron results in increased expression of BBLN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:15,674,577...15,677,393
Ensembl chr 3:15,674,580...15,677,374
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
decreases expression |
EXP |
Diuron results in decreased expression of BCL11A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bex3 |
brain expressed X-linked 3 |
increases expression |
EXP |
Diuron results in increased expression of BEX3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:99,273,238...99,274,799
Ensembl chr X:99,273,161...99,274,800
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
decreases expression |
EXP |
Diuron results in decreased expression of BHLHE41 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:178,833,085...178,838,685
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bicdl1 |
BICD family like cargo adaptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of BICDL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:40,878,190...41,001,152
Ensembl chr12:40,876,884...40,966,130
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
EXP |
Diuron results in increased expression of BIK mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Bin2 |
bridging integrator 2 |
increases expression |
EXP |
Diuron results in increased expression of BIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:131,742,001...131,768,208
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Blnk |
B-cell linker |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of BLNK mRNA Diuron results in increased expression of BLNK mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression increases expression |
EXP ISO |
Diuron results in decreased expression of BMP6 mRNA Diuron metabolite results in increased expression of BMP6 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BMPR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Bnc1 |
basonuclin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of BNC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:135,917,676...135,943,333
Ensembl chr 1:135,917,687...135,943,333
|
|
G |
Bnc2 |
basonuclin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BNC2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:98,679,071...99,079,742
Ensembl chr 5:98,687,410...99,079,426
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
increases expression |
EXP |
Diuron results in increased expression of BOK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Bphl |
biphenyl hydrolase like |
decreases expression |
EXP |
Diuron results in decreased expression of BPHL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
decreases expression |
EXP |
Diuron results in decreased expression of BPTF mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769
|
|
G |
Brd4 |
bromodomain containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of BRD4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Brf2 |
BRF2, RNA polymerase III transcription initiation factor subunit |
increases expression |
EXP |
Diuron results in increased expression of BRF2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:64,928,334...64,933,057
Ensembl chr16:64,928,300...64,933,059
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
increases expression |
EXP |
Diuron results in increased expression of BRINP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
|
|
G |
Bsg |
basigin (Ok blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of BSG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Bspry |
B-box and SPRY domain containing |
decreases expression |
EXP |
Diuron results in decreased expression of BSPRY mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:75,927,397...75,949,585
Ensembl chr 5:75,927,405...75,949,583
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
EXP |
Diuron results in decreased expression of BST2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:18,217,404...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
increases expression |
EXP |
Diuron results in increased expression of BZW1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
|
|
G |
C18h18orf32 |
similar to human chromosome 18 open reading frame 32 |
decreases expression |
EXP |
Diuron results in decreased expression of C18H18ORF32 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QB mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1qbp |
complement C1q binding protein |
increases expression |
EXP |
Diuron results in increased expression of C1QBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
Diuron results in decreased expression of C1QC mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C1qtnf2 |
C1q and TNF related 2 |
decreases expression |
EXP |
Diuron results in decreased expression of C1QTNF2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
decreases expression |
EXP |
Diuron results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
|
|
G |
C1r |
complement C1r |
decreases expression |
EXP |
Diuron results in decreased expression of C1R mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C1s |
complement C1s |
decreases expression |
EXP |
Diuron results in decreased expression of C1S mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2 |
complement C2 |
decreases expression |
EXP |
Diuron results in decreased expression of C2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
decreases expression |
EXP |
Diuron results in decreased expression of C2CD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
|
|
G |
C2cd2l |
C2CD2-like |
decreases expression |
EXP |
Diuron results in decreased expression of C2CD2L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340
|
|
G |
C3 |
complement C3 |
increases expression |
ISO EXP |
Diuron metabolite results in increased expression of C3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4b |
complement C4B (Chido blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of C4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C7 |
complement C7 |
decreases expression |
EXP |
Diuron results in decreased expression of C7 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8h11orf71 |
similar to human chromosome 11 open reading frame 71 |
increases expression |
EXP |
Diuron results in increased expression of C8H11ORF71 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:48,838,556...48,838,970
Ensembl chr 8:48,838,100...48,842,270
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
increases expression |
EXP |
Diuron results in increased expression of C8H15ORF39 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
increases expression |
EXP |
Diuron results in increased expression of CAAP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
Diuron results in increased expression of CADM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Cadm3 |
cell adhesion molecule 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CADM3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:85,786,482...85,817,412
Ensembl chr13:85,786,483...85,817,749
|
|
G |
Cald1 |
caldesmon 1 |
increases expression |
EXP |
Diuron results in increased expression of CALD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:63,265,781...63,446,936
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CALM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calm2 |
calmodulin 2 |
increases expression |
EXP |
Diuron results in increased expression of CALM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
|
|
G |
Calml3 |
calmodulin-like 3 |
increases expression |
EXP |
Diuron results in increased expression of CALML3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Calml4 |
calmodulin-like 4 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of CALML4 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
decreases expression |
EXP |
Diuron results in decreased expression of CAMK2D mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Canx |
calnexin |
decreases expression |
EXP |
Diuron results in decreased expression of CANX mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Capg |
capping actin protein, gelsolin like |
decreases expression |
EXP |
Diuron results in decreased expression of CAPG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn2 |
calpain 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAPN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Capn9 |
calpain 9 |
increases expression |
EXP |
Diuron results in increased expression of CAPN9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CAPRIN1 mRNA Diuron results in decreased expression of CAPRIN1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
EXP |
Diuron results in increased expression of CAR12 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CAR3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car5b |
carbonic anhydrase 5B |
increases expression |
EXP |
Diuron results in increased expression of CA5B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:30,474,697...30,534,797
Ensembl chr X:30,474,784...30,533,837
|
|
G |
Car8 |
carbonic anhydrase 8 |
decreases expression |
EXP |
Diuron results in decreased expression of CAR8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
|
|
G |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
increases expression |
EXP |
Diuron results in increased expression of CARMIL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
|
|
G |
Casq1 |
calsequestrin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CASQ1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:84,670,648...84,680,339
Ensembl chr13:84,670,649...84,680,339
|
|
G |
Cast |
calpastatin |
decreases expression |
EXP |
Diuron results in decreased expression of CAST mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
Diuron results in decreased expression of CAT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CAV1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAV2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CAVIN3 mRNA Diuron results in decreased expression of CAVIN3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cbl |
Cbl proto-oncogene |
decreases expression |
EXP |
Diuron results in decreased expression of CBL mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Cblb |
Cbl proto-oncogene B |
increases expression |
EXP |
Diuron results in increased expression of CBLB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Cbr3 |
carbonyl reductase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CBR3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CCDC113 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc152 |
coiled-coil domain containing 152 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC152 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:52,507,987...52,532,880
Ensembl chr 2:52,507,981...52,532,826
|
|
G |
Ccdc62 |
coiled-coil domain containing 62 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC62 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:32,623,170...32,659,912
Ensembl chr12:32,623,170...32,660,017
|
|
G |
Ccdc69 |
coiled-coil domain containing 69 |
increases expression |
EXP |
Diuron results in increased expression of CCDC69 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:39,173,282...39,200,358
Ensembl chr10:39,173,282...39,199,878
|
|
G |
Ccdc77 |
coiled-coil domain containing 77 |
increases expression |
EXP |
Diuron results in increased expression of CCDC77 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:153,534,184...153,566,059
Ensembl chr 4:153,534,187...153,566,545
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
decreases expression |
EXP |
Diuron results in decreased expression of CCDC80 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
decreases expression |
EXP |
Diuron results in decreased expression of CCL11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
increases expression |
EXP |
Diuron results in increased expression of CCL21 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
|
|
G |
Ccl6 |
C-C motif chemokine ligand 6 |
decreases expression |
EXP |
Diuron results in decreased expression of CCL6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:68,381,179...68,385,811
Ensembl chr10:68,380,188...68,384,001
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CCN1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of CCN2 mRNA Diuron metabolite results in decreased expression of CCN2 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn3 |
cellular communication network factor 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CCN3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccndbp1 |
cyclin D1 binding protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CCNDBP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:107,962,402...107,974,234
Ensembl chr 3:107,962,261...107,974,233
|
|
G |
Ccni |
cyclin I |
decreases expression |
EXP |
Diuron results in decreased expression of CCNI mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510
|
|
G |
Ccnl2 |
cyclin L2 |
decreases expression |
EXP |
Diuron results in decreased expression of CCNL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:166,416,940...166,428,997
Ensembl chr 5:166,417,508...166,436,882
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CCPG1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Cd163 |
CD163 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD163 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd164 |
CD164 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD164 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:45,024,051...45,035,628
Ensembl chr20:45,023,973...45,035,634
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD24 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd248 |
CD248 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD248 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:202,373,676...202,376,240
Ensembl chr 1:202,373,676...202,376,240
|
|
G |
Cd302 |
CD302 molecule |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CD302 mRNA Diuron results in decreased expression of CD302 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:44,722,324...44,756,045
Ensembl chr 3:44,722,325...44,756,045
|
|
G |
Cd34 |
CD34 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD34 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:106,480,074...106,499,462
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD36 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd3g |
CD3 gamma subunit of T-cell receptor complex |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of CD3G mRNA Diuron results in increased expression of CD3G mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:45,280,797...45,287,271
Ensembl chr 8:45,281,204...45,287,147
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
EXP |
Diuron results in increased expression of CD44 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd48 |
Cd48 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD48 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
decreases expression |
EXP |
Diuron results in decreased expression of CD55 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd59 |
CD59 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD59 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD63 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD74 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD86 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd9 |
CD9 molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CD9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cd93 |
CD93 molecule |
increases expression |
EXP |
Diuron results in increased expression of CD93 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
|
|
G |
Cdc42ep2 |
CDC42 effector protein 2 |
increases expression |
EXP |
Diuron results in increased expression of CDC42EP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
increases expression |
EXP |
Diuron results in increased expression of CDC42EP4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
|
|
G |
Cdc42se2 |
CDC42 small effector 2 |
increases expression |
EXP |
Diuron results in increased expression of CDC42SE2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059
|
|
G |
Cdca7 |
cell division cycle associated 7 |
increases expression |
EXP |
Diuron results in increased expression of CDCA7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CDCP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
EXP |
Diuron results in decreased expression of CDH11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh22 |
cadherin 22 |
decreases expression |
EXP |
Diuron results in decreased expression of CDH22 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
|
|
G |
Cdh5 |
cadherin 5 |
increases expression |
EXP |
Diuron results in increased expression of CDH5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of CDK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
EXP |
Diuron results in increased expression of CDKN1C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CDO1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdpf1 |
cysteine rich, DPF motif domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CDPF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:116,896,672...116,905,542
Ensembl chr 7:116,901,003...116,905,406
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CEACAM1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
EXP |
Diuron results in increased expression of CEBPG mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CELF2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cep126 |
centrosomal protein 126 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CEP126 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467
|
|
G |
Cercam |
cerebral endothelial cell adhesion molecule |
decreases expression |
EXP |
Diuron results in decreased expression of CERCAM mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:13,118,150...13,155,960
Ensembl chr 3:13,142,107...13,155,956
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CES1D mRNA Diuron results in decreased expression of CES1D mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces5a |
carboxylesterase 5A |
decreases expression |
EXP |
Diuron results in decreased expression of CES5A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:11,469,469...11,499,007
Ensembl chr19:11,469,469...11,499,006
|
|
G |
Cesl1 |
carboxylesterase-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CESL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608
|
|
G |
Cfap20dc |
CFAP20 domain containing |
increases expression |
ISO |
Diuron metabolite results in increased expression of CFAP20DC mRNA |
CTD |
PMID:24172598 |
|
NCBI chr15:16,231,248...16,476,978
Ensembl chr15:16,231,299...16,476,977
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CFAP300 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfb |
complement factor B |
decreases expression |
EXP |
Diuron results in decreased expression of CFB mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfd |
complement factor D |
decreases expression |
EXP |
Diuron results in decreased expression of CFD mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cfh |
complement factor H |
decreases expression |
EXP |
Diuron results in decreased expression of CFH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Cfl2 |
cofilin 2 |
increases expression |
EXP |
Diuron results in increased expression of CFL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:72,355,664...72,359,709
Ensembl chr 6:72,355,664...72,359,674
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
EXP |
Diuron results in increased expression of CFLAR mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cgnl1 |
cingulin-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CGNL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:72,273,401...72,424,842
Ensembl chr 8:72,275,645...72,422,917
|
|
G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CHD2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
decreases expression |
EXP |
Diuron results in decreased expression of CHD4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases expression |
EXP |
Diuron results in increased expression of CHEK2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
increases expression |
EXP |
Diuron results in increased expression of CHMP2A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CHORDC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CHP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
|
|
G |
Chpf |
chondroitin polymerizing factor |
decreases expression |
EXP |
Diuron results in decreased expression of CHPF mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chrnb1 |
cholinergic receptor nicotinic beta 1 subunit |
increases expression |
EXP |
Diuron results in increased expression of CHRNB1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345
|
|
G |
Churc1 |
churchill domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of CHURC1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:95,464,488...95,485,208
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Cib2 |
calcium and integrin binding family member 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CIB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:54,930,265...54,947,157
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
decreases expression |
EXP |
Diuron results in decreased expression of CIDEA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
Diuron results in decreased expression of CIDEC mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of CILK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Cisd3 |
CDGSH iron sulfur domain 3 |
increases expression |
EXP |
Diuron results in increased expression of CISD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:82,679,345...82,682,376
Ensembl chr10:82,679,196...82,682,550
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CITED2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
EXP |
Diuron results in decreased expression of CKM mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CLDN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn11 |
claudin 11 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of CLDN11 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
decreases expression |
EXP |
Diuron results in decreased expression of CLEC10A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
increases expression |
EXP |
Diuron results in increased expression of CLEC11A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:94,800,456...94,809,002
Ensembl chr 1:94,801,496...94,804,633
|
|
G |
Clgn |
calmegin |
increases expression |
ISO |
Diuron metabolite results in increased expression of CLGN mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
|
|
G |
Clic2 |
chloride intracellular channel 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
|
|
G |
Clic3 |
chloride intracellular channel 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
|
|
G |
Clic4 |
chloride intracellular channel 4 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIC4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:147,456,819...147,513,278
Ensembl chr 5:147,453,712...147,513,452
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CLIP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression decreases expression |
EXP |
Diuron results in increased expression of CLMP mRNA Diuron results in decreased expression of CLMP mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:41,060,527...41,168,841
Ensembl chr 8:41,060,799...41,168,838
|
|
G |
Cln5 |
CLN5, intracellular trafficking protein |
increases expression |
EXP |
Diuron results in increased expression of CLN5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:79,893,573...79,903,438
Ensembl chr15:79,893,548...79,903,438
|
|
G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
decreases expression |
EXP |
Diuron results in decreased expression of CMAS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:175,718,808...175,737,128
Ensembl chr 4:175,718,808...175,737,125
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CMPK2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cmtm7 |
CKLF-like MARVEL transmembrane domain containing 7 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:114,448,037...114,474,958
Ensembl chr 8:114,448,042...114,474,621
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTM8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CMTR1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CNDP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CNDP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
EXP |
Diuron results in increased expression of CNN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
EXP |
Diuron results in decreased expression of CNN3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
decreases expression |
EXP |
Diuron results in decreased expression of COBL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
|
|
G |
Col11a2 |
collagen type XI alpha 2 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL11A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:4,786,929...4,816,598
Ensembl chr20:4,786,929...4,815,985
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL12A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL14A1 mRNA Diuron results in decreased expression of COL14A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL15A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL1A1 mRNA Diuron results in decreased expression of COL1A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL1A2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL4A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
increases expression |
EXP |
Diuron results in increased expression of COL4A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL5A1 mRNA Diuron results in decreased expression of COL5A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL5A2 mRNA Diuron results in decreased expression of COL5A2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL5A3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL6A1 mRNA Diuron results in decreased expression of COL6A1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression decreases expression |
EXP |
Diuron results in increased expression of COL6A2 mRNA Diuron results in decreased expression of COL6A2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
EXP |
Diuron results in increased expression of COL6A3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Col6a6 |
collagen type VI alpha 6 chain |
decreases expression |
EXP |
Diuron results in decreased expression of COL6A6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:106,318,010...106,473,419
Ensembl chr 8:106,306,422...106,473,472
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
increases expression |
EXP |
Diuron results in increased expression of COL7A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:109,604,877...109,637,252
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Colgalt1 |
collagen beta(1-O)galactosyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of COLGALT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:18,319,796...18,332,106
Ensembl chr16:18,319,795...18,332,106
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
EXP |
Diuron results in decreased expression of COMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
decreases expression |
EXP |
Diuron results in decreased expression of COPG2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Coq10b |
coenzyme Q10B |
increases expression |
EXP |
Diuron results in increased expression of COQ10B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
increases expression |
EXP |
Diuron results in increased expression of COQ3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
increases expression |
EXP |
Diuron results in increased expression of COQ6 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 6:104,007,814...104,019,888
Ensembl chr 6:104,007,872...104,024,657
|
|
G |
Coro6 |
coronin 6 |
increases expression |
EXP |
Diuron results in increased expression of CORO6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
increases expression |
EXP |
Diuron results in increased expression of COX5A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
EXP |
Diuron results in decreased expression of CP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression |
EXP |
Diuron results in decreased expression of CPE mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CPEB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
|
|
G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
increases expression |
EXP |
Diuron results in increased expression of CPEB4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:15,717,794...15,780,482
Ensembl chr10:15,717,794...15,780,603
|
|
G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CPED1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
EXP |
Diuron results in decreased expression of PGCP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
EXP |
Diuron results in increased expression of CPT1C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
EXP |
Diuron results in increased expression of CPT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cpxm1 |
carboxypeptidase X (M14 family), member 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CPXM1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:117,588,532...117,595,330
|
|
G |
Cracr2b |
calcium release activated channel regulator 2B |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of CRACR2B mRNA Diuron results in increased expression of CRACR2B mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:196,558,407...196,563,961
Ensembl chr 1:196,558,588...196,563,771
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
EXP |
Diuron results in decreased expression of CREBBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
increases expression |
EXP |
Diuron results in increased expression of CREBZF mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
EXP |
Diuron results in increased expression of CRELD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
decreases expression |
EXP |
Diuron results in decreased expression of CRELD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CRIM1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Crip1 |
cysteine rich protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CRIP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
increases expression |
EXP |
Diuron results in increased expression of CRK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
EXP |
Diuron results in increased expression of CRYAB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CSF3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSGALNACT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
|
|
G |
Csn1s1 |
casein alpha s1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSN1S1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:20,343,620...20,359,614
Ensembl chr14:20,343,619...20,359,614
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CSNK1A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
EXP |
Diuron results in increased expression of CSRP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cst3 |
cystatin C |
increases expression |
EXP |
Diuron results in increased expression of CST3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Cst6 |
cystatin E/M |
increases expression |
EXP |
Diuron results in increased expression of CST6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
|
|
G |
Cstb |
cystatin B |
increases expression |
ISO |
Diuron metabolite results in increased expression of CSTB mRNA |
CTD |
PMID:24172598 |
|
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression |
EXP |
Diuron results in increased expression of CTNNB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctps2 |
CTP synthase 2 |
increases expression |
EXP |
Diuron results in increased expression of CTPS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733
|
|
G |
Ctsb |
cathepsin B |
decreases expression |
EXP |
Diuron results in decreased expression of CTSB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
EXP |
Diuron results in decreased expression of CTSD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctse |
cathepsin E |
increases expression |
EXP |
Diuron metabolite results in increased expression of CTSE mRNA; Diuron results in increased expression of CTSE mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
EXP |
Diuron results in decreased expression of CTSK mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ctss |
cathepsin S |
decreases expression |
EXP |
Diuron results in decreased expression of CTSS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CX3CL1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CXCL1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression decreases expression |
EXP |
Diuron metabolite results in increased expression of CXCL12 mRNA Diuron results in decreased expression of CXCL12 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
EXP |
Diuron results in increased expression of CXCL14 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:8,317,933...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CXCL2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CXCL5 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
EXP |
Diuron results in decreased expression of CXCL9 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
EXP |
Diuron results in increased expression of CXCR4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cxxc5 |
CXXC finger protein 5 |
decreases expression |
EXP |
Diuron results in decreased expression of CXXC5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,427,230...27,458,673
|
|
G |
Cyb561 |
cytochrome b-561 |
decreases expression |
EXP |
Diuron results in decreased expression of CYB561 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
|
|
G |
Cygb |
cytoglobin |
decreases expression |
EXP |
Diuron results in decreased expression of CYGB mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity increases expression decreases expression |
ISO EXP |
Diuron results in increased activity of CYP1A1 protein Diuron metabolite results in increased expression of CYP1A1 mRNA; Diuron results in increased expression of CYP1A1 mRNA; Diuron results in increased expression of CYP1A1 protein Diuron results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:8812189 PMID:16788953 PMID:21551480 PMID:21784029 PMID:24172598 PMID:25152437 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
Diuron results in increased expression of CYP1A2 mRNA; Diuron results in increased expression of CYP1A2 protein |
CTD |
PMID:21784029 PMID:22310298 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of CYP1B1 mRNA Diuron metabolite results in increased expression of CYP1B1 mRNA Diuron results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
increases expression |
EXP |
Diuron metabolite results in increased expression of CYP26B1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
EXP |
Diuron results in increased expression of CYP27A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Diuron results in increased expression of CYP2B6 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP2U1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:219,849,403...219,866,959
Ensembl chr 2:219,849,407...219,866,882
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:8,880,528...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Diuron results in increased expression of CYP3A4 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
Diuron results in increased expression of CYP3A23-3A1 protein |
CTD |
PMID:8812189 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
Diuron metabolite results in increased expression of CYP4F3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
Diuron results in decreased expression of CYP51 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cytl1 |
cytokine like 1 |
increases expression |
EXP |
Diuron results in increased expression of CYTL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:73,053,876...73,058,886
Ensembl chr14:73,053,877...73,058,886
|
|
G |
Dab2 |
DAB adaptor protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DAB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DACT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DACT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
Diuron results in increased expression of DAP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dbn1 |
drebrin 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DBN1 mRNA Diuron results in decreased expression of DBN1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dbnl |
drebrin-like |
increases expression |
EXP |
Diuron results in increased expression of DBNL mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
Diuron results in increased expression of DBP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
EXP |
Diuron results in decreased expression of DCAF11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DCLK1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Dcn |
decorin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DCN mRNA Diuron results in decreased expression of DCN mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
EXP |
Diuron results in decreased expression of DCT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Dctn3 |
dynactin subunit 3 |
increases expression |
EXP |
Diuron results in increased expression of DCTN3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:56,881,085...56,889,041
Ensembl chr 5:56,881,085...56,889,102
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DDAH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DDAH2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DDB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
EXP |
Diuron results in decreased expression of DDIT4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DDR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
decreases expression |
EXP |
Diuron results in decreased expression of DDX5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Def8 |
differentially expressed in FDCP 8 homolog |
increases expression |
EXP |
Diuron results in increased expression of DEF8 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638
|
|
G |
Depdc7 |
DEP domain containing 7 |
increases expression |
EXP |
Diuron results in increased expression of DEPDC7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
increases expression |
EXP |
Diuron results in increased expression of DERA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:170,663,646...170,742,469
Ensembl chr 4:170,663,665...170,758,865
|
|
G |
Des |
desmin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DES mRNA Diuron results in decreased expression of DES mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
EXP |
Diuron results in increased expression of DGAT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
EXP |
Diuron results in increased expression of DHRS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DHRS3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of DHRS4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
decreases expression |
EXP |
Diuron results in decreased expression of DHX36 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
|
|
G |
Dhx40 |
DEAH-box helicase 40 |
increases expression |
EXP |
Diuron results in increased expression of DHX40 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:71,584,546...71,621,479
Ensembl chr10:71,583,716...71,621,445
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DKK2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225
|
|
G |
Dlg3 |
discs large MAGUK scaffold protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DLG3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
|
|
G |
Dmpk |
DM1 protein kinase |
increases expression |
EXP |
Diuron results in increased expression of DMPK mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
|
|
G |
Dmxl2 |
Dmx-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DMXL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:54,741,164...54,884,948
Ensembl chr 8:54,741,160...54,885,161
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression |
EXP |
Diuron results in increased expression of DNAJA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:55,085,246...55,102,715
Ensembl chr 8:55,085,464...55,101,207
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
EXP |
Diuron results in increased expression of DNAJB1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:24,522,717...24,526,458
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb2 |
DnaJ heat shock protein family (Hsp40) member B2 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJB2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277
|
|
G |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
increases expression |
EXP |
Diuron results in increased expression of DNAJB3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
EXP |
Diuron results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DNASE1L3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
Diuron metabolite results in increased expression of DNER mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 9:85,586,985...85,902,820
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dock11 |
dedicator of cytokinesis 11 |
decreases expression |
EXP |
Diuron results in decreased expression of DOCK11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression decreases expression |
ISO EXP |
Diuron metabolite results in increased expression of DPP4 mRNA Diuron results in decreased expression of DPP4 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr 3:46,962,243...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpt |
dermatopontin |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DPT mRNA Diuron results in decreased expression of DPT mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:77,122,926...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DPYSL2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
increases expression |
EXP |
Diuron results in increased expression of DRAM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
|
|
G |
Dsel |
dermatan sulfate epimerase-like |
decreases expression |
EXP |
Diuron results in decreased expression of DSEL mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:186,413...192,592
Ensembl chr13:175,805...192,647
|
|
G |
Dtnb |
dystrobrevin, beta |
decreases expression |
EXP |
Diuron results in decreased expression of DTNB mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335
|
|
G |
Dusp14 |
dual specificity phosphatase 14 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of DUSP14 mRNA Diuron metabolite results in decreased expression of DUSP14 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of DUSP5 mRNA Diuron results in increased expression of DUSP5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
EXP |
Diuron results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:41,312,367...41,314,742
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Dynll2 |
dynein light chain LC8-type 2 |
decreases expression |
EXP |
Diuron results in decreased expression of DYNLL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
|
|
G |
Dzip3 |
DAZ interacting zinc finger protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of DZIP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353
|
|
G |
Ebf1 |
EBF transcription factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EBF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ebf3 |
EBF transcription factor 3 |
decreases expression |
EXP |
Diuron results in decreased expression of EBF3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:191,996,726...192,114,713
Ensembl chr 1:191,996,730...192,114,359
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
EXP |
Diuron results in increased expression of ECH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
EXP |
Diuron results in increased expression of ECM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Ecrg4 |
ECRG4 augurin precursor |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ECRG4 mRNA Diuron results in decreased expression of ECRG4 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of EEPD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EFEMP1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of EFEMP2 mRNA Diuron results in decreased expression of EFEMP2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
decreases expression |
EXP |
Diuron results in decreased expression of EFHD1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Egfl7 |
EGF-like-domain, multiple 7 |
increases expression |
EXP |
Diuron results in increased expression of EGFL7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
EXP |
Diuron results in increased expression of EGR2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Ehd2 |
EH-domain containing 2 |
increases expression |
EXP |
Diuron results in increased expression of EHD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:76,639,568...76,658,747
Ensembl chr 1:76,637,482...76,658,783
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF2AK4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:105,356,261...105,441,630
Ensembl chr 3:105,356,261...105,441,630
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
increases expression |
EXP |
Diuron results in increased expression of EIF4A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:54,384,345...54,389,853
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
increases expression |
EXP |
Diuron results in increased expression of EIF4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EIF4G1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
increases expression |
EXP |
Diuron results in increased expression of EIF6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Elf5 |
E74 like ETS transcription factor 5 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of ELF5 mRNA Diuron results in increased expression of ELF5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 3:89,808,836...89,836,977
Ensembl chr 3:89,797,880...89,836,973
|
|
G |
Elk3 |
ETS transcription factor ELK3 |
increases expression |
EXP |
Diuron results in increased expression of ELK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084
|
|
G |
Elmo3 |
engulfment and cell motility 3 |
decreases expression |
EXP |
Diuron results in decreased expression of ELMO3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:33,181,952...33,186,399
Ensembl chr19:33,182,036...33,186,410
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ELOVL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
EXP |
Diuron results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emcn |
endomucin |
increases expression |
EXP |
Diuron results in increased expression of EMCN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929
|
|
G |
Emid1 |
EMI domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EMID1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
EXP |
Diuron results in increased expression of EMILIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:25,455,974...25,463,736
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Emilin2 |
elastin microfibril interfacer 2 |
decreases expression |
EXP |
Diuron results in decreased expression of EMILIN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:111,160,708...111,220,463
Ensembl chr 9:111,160,712...111,220,352
|
|
G |
Eml1 |
EMAP like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EML1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
EXP |
Diuron results in decreased expression of EML4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emp3 |
epithelial membrane protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of EMP3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Eno1 |
enolase 1 |
increases expression |
EXP |
Diuron results in increased expression of ENO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ENO2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ENPP2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 |
increases expression |
EXP |
Diuron results in increased expression of ENPP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of ENTPD1 mRNA Diuron results in decreased expression of ENTPD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of ENTPD2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
increases expression |
ISO |
Diuron metabolite results in increased expression of ENTPD3 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
EXP |
Diuron results in increased expression of ENTPD5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ENTREP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of EPB41L2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
Diuron results in increased expression of EPHX1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
increases expression |
EXP |
Diuron results in increased expression of EPHX2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Eppk1 |
epiplakin 1 |
increases expression |
EXP |
Diuron results in increased expression of EPPK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
|
|
G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
decreases expression |
EXP |
Diuron results in decreased expression of EPRS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
increases expression |
EXP |
Diuron results in increased expression of ERGIC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Erlin1 |
ER lipid raft associated 1 |
increases expression |
EXP |
Diuron results in increased expression of ERLIN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:242,921,147...242,956,472
Ensembl chr 1:242,921,152...242,956,394
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of ERP27 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ERRFI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esco1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
increases expression |
EXP |
Diuron results in increased expression of ESCO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
|
|
G |
Esd |
esterase D |
decreases expression |
EXP |
Diuron results in decreased expression of ESD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Diuron binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Diuron binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrp1 |
epithelial splicing regulatory protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of ESRP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
|
|
G |
Etfbkmt |
electron transfer flavoprotein subunit beta lysine methyltransferase |
increases expression |
EXP |
Diuron results in increased expression of ETFBKMT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:182,140,492...182,204,635
Ensembl chr 4:182,140,559...182,150,305
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
increases expression |
EXP |
Diuron results in increased expression of ETHE1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
increases expression |
EXP |
Diuron results in increased expression of ETS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
EXP |
Diuron results in increased expression of ETS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Eva1b |
eva-1 homolog B |
decreases expression |
EXP |
Diuron results in decreased expression of EVA1B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:138,427,083...138,429,602
Ensembl chr 5:138,427,151...138,432,433
|
|
G |
Exo5 |
exonuclease 5 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of EXO5 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 5:134,494,440...134,497,757
Ensembl chr 5:134,493,829...134,497,772
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
EXP |
Diuron results in increased expression of EXOC3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Exosc7 |
exosome component 7 |
increases expression |
EXP |
Diuron results in increased expression of EXOSC7 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:122,773,591...122,799,270
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of EXT1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
decreases expression |
EXP |
Diuron results in decreased expression of EZH1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:86,126,023...86,162,001
Ensembl chr10:86,126,015...86,161,921
|
|
G |
Ezr |
ezrin |
increases expression |
EXP |
Diuron results in increased expression of EZR mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
decreases expression |
EXP |
Diuron results in decreased expression of F13A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
increases expression |
EXP |
Diuron results in increased expression of F2R mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
EXP |
Diuron results in decreased expression of F3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
EXP |
Diuron results in increased expression of FAAH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression |
EXP |
Diuron results in increased expression of FABP5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases expression |
EXP |
Diuron results in increased expression of FADS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam102b |
family with sequence similarity 102, member B |
decreases expression |
EXP |
Diuron results in decreased expression of FAM102B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
EXP |
Diuron results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:43,275,693...43,346,227
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam118a |
family with sequence similarity 118, member A |
increases expression |
EXP |
Diuron results in increased expression of FAM118A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:116,152,448...116,178,976
Ensembl chr 7:116,146,716...116,178,971
|
|
G |
Fam136a |
family with sequence similarity 136, member A |
increases expression |
EXP |
Diuron results in increased expression of FAM136A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:118,805,129...118,811,046
Ensembl chr 4:118,805,127...118,811,047
|
|
G |
Fam171b |
family with sequence similarity 171, member B |
decreases expression |
EXP |
Diuron results in decreased expression of FAM171B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
decreases expression |
EXP |
Diuron results in decreased expression of FAM174C mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
decreases expression |
EXP |
Diuron results in decreased expression of FAM25A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:9,680,668...9,684,474
Ensembl chr16:9,680,668...9,684,474
|
|
G |
Fam3b |
FAM3 metabolism regulating signaling molecule B |
increases expression |
EXP |
Diuron results in increased expression of FAM3B mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:36,831,532...36,863,902
Ensembl chr11:36,831,532...36,869,713
|
|
G |
Fam83f |
family with sequence similarity 83, member F |
increases expression |
EXP |
Diuron results in increased expression of FAM83F mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452
|
|
G |
Fam91a1 |
family with sequence similarity 91, member A1 |
increases expression |
EXP |
Diuron results in increased expression of FAM91A1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:89,969,558...90,007,546
Ensembl chr 7:89,969,605...90,007,556
|
|
G |
Fam98a |
family with sequence similarity 98, member A |
decreases expression |
EXP |
Diuron results in decreased expression of FAM98A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
|
|
G |
Fap |
fibroblast activation protein, alpha |
decreases expression |
EXP |
Diuron results in decreased expression of FAP mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:47,138,823...47,207,671
Ensembl chr 3:47,138,813...47,225,545
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FARP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression |
EXP |
Diuron results in decreased expression of FAS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
EXP |
Diuron results in increased expression of FBLN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbln2 |
fibulin 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FBLN2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FBN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
increases expression |
EXP |
Diuron results in increased expression of FBXL22 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685
|
|
G |
Fbxo22 |
F-box protein 22 |
decreases expression |
EXP |
Diuron results in decreased expression of FBXO22 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fbxo6 |
F-box protein 6 |
increases expression |
EXP |
Diuron results in increased expression of FBXO6 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
decreases expression |
EXP |
Diuron results in decreased expression of FCER1G mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:83,649,447...83,654,215
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
decreases expression |
EXP |
Diuron results in decreased expression of FCGR2A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fcmr |
Fc mu receptor |
decreases expression |
EXP |
Diuron results in decreased expression of FCMR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
|
|
G |
Fcna |
ficolin A |
decreases expression |
EXP |
Diuron results in decreased expression of FCNA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:8,445,904...8,449,128
Ensembl chr 3:8,445,907...8,449,105
|
|
G |
Fcrl2 |
Fc receptor-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FCRLS mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:172,694,308...172,707,261
Ensembl chr 2:172,694,308...172,707,051
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
EXP |
Diuron results in decreased expression of FDPS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fem1b |
fem-1 homolog B |
increases expression |
EXP |
Diuron results in increased expression of FEM1B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:63,265,301...63,278,577
Ensembl chr 8:63,265,301...63,278,577
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FERMT2 mRNA Diuron results in decreased expression of FERMT2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FEZ2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FGF1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
decreases expression |
EXP |
Diuron results in decreased expression of FGF18 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of FGFBP1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FGFR1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
EXP |
Diuron results in decreased expression of FGG mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgl2 |
fibrinogen-like 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FGL2 mRNA Diuron results in decreased expression of FGL2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FHL1 mRNA Diuron results in decreased expression of FHL1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
EXP |
Diuron results in increased expression of FHL2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:45,388,979...45,462,530
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fibin |
fin bud initiation factor homolog |
decreases expression |
EXP |
Diuron results in decreased expression of FIBIN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
EXP |
Diuron results in increased expression of FIBP mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
increases expression |
EXP |
Diuron results in increased expression of FILIP1L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
|
|
G |
Fis1 |
fission, mitochondrial 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FIS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:19,708,558...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
decreases expression |
EXP |
Diuron results in decreased expression of FKBP11 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression |
EXP |
Diuron results in increased expression of FKBP1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of FKBP1B mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Flcn |
folliculin |
decreases expression |
EXP |
Diuron results in decreased expression of FLCN mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flna |
filamin A |
increases expression |
EXP |
Diuron results in increased expression of FLNA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression |
EXP |
Diuron results in increased expression of FLT1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmnl2 |
formin-like 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FMNL2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FMO2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of FMO3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
Diuron results in increased expression of FMO5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fmod |
fibromodulin |
decreases expression |
EXP |
Diuron results in decreased expression of FMOD mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FN1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
decreases expression |
EXP |
Diuron results in decreased expression of FNDC1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259
|
|
G |
Folr2 |
folate receptor beta |
decreases expression |
EXP |
Diuron results in decreased expression of FOLR2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression |
EXP |
Diuron results in decreased expression of FOXN3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Foxp1 |
forkhead box P1 |
decreases expression |
EXP |
Diuron results in decreased expression of FOXP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
increases expression |
EXP |
Diuron results in increased expression of FRS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:52,711,255...52,792,758
Ensembl chr 7:52,711,257...52,792,743
|
|
G |
Fry |
FRY microtubule binding protein |
increases expression |
EXP |
Diuron results in increased expression of FRY mRNA |
CTD |
PMID:21551480 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fst |
follistatin |
decreases expression |
EXP |
Diuron results in decreased expression of FST mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fstl1 |
follistatin-like 1 |
increases expression decreases expression |
EXP ISO |
Diuron results in increased expression of FSTL1 mRNA Diuron metabolite results in decreased expression of FSTL1 mRNA Diuron results in decreased expression of FSTL1 mRNA |
CTD |
PMID:21551480 PMID:24172598 PMID:25152437 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
increases expression |
EXP |
Diuron results in increased expression of FUCA2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
|
|
G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of FXYD1 mRNA Diuron results in decreased expression of FXYD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
decreases expression |
EXP |
Diuron results in decreased expression of FXYD2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:45,712,887...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
increases expression |
EXP |
Diuron results in increased expression of FXYD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:86,305,531...86,312,455
|
|
G |
Fxyd4 |
FXYD domain-containing ion transport regulator 4 |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of FXYD4 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 4:151,109,779...151,113,659
Ensembl chr 4:151,109,779...151,113,637
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
EXP |
Diuron results in increased expression of FXYD5 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Fyb1 |
FYN binding protein 1 |
increases expression |
ISO |
Diuron metabolite results in increased expression of FYB1 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
Diuron results in decreased expression of FYN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of G0S2 mRNA Diuron results in decreased expression of G0S2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
Diuron results in increased expression of G6PD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases expression |
EXP |
Diuron results in increased expression of GALNT11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
decreases expression |
EXP |
Diuron results in decreased expression of GALNT16 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
EXP |
Diuron results in decreased expression of GAP43 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
EXP |
Diuron results in decreased expression of GAS5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gas6 |
growth arrest specific 6 |
decreases expression |
EXP |
Diuron results in decreased expression of GAS6 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gask1b |
golgi associated kinase 1B |
decreases expression |
ISO |
Diuron metabolite results in decreased expression of GASK1B mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gata3 |
GATA binding protein 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GATA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
increases expression |
EXP |
Diuron results in increased expression of GATAD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:30,507,530...30,519,109
Ensembl chr 4:30,507,538...30,519,107
|
|
G |
Gbf1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GBF1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 1:245,018,535...245,147,052
Ensembl chr 1:245,018,568...245,147,042
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GBP2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gca |
grancalcin |
decreases expression |
EXP |
Diuron results in decreased expression of GCA mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:47,297,320...47,328,581
Ensembl chr 3:47,297,383...47,328,581
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP |
Diuron results in increased expression of GCLC mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GCNT2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr17:23,796,859...23,901,625 NCBI chr17:23,866,602...23,868,691
Ensembl chr17:23,796,859...23,901,611
|
|
G |
Gda |
guanine deaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GDA mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
increases expression |
EXP |
Diuron results in increased expression of GDE1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:173,016,984...173,032,396
Ensembl chr 1:172,954,394...173,032,429
|
|
G |
Gdf10 |
growth differentiation factor 10 |
decreases expression |
EXP |
Diuron results in decreased expression of GDF10 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
EXP |
Diuron results in increased expression of GDF11 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
EXP |
Diuron metabolite results in increased expression of GDF15 mRNA; Diuron results in increased expression of GDF15 mRNA |
CTD |
PMID:24172598 PMID:25152437 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GDI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gdpd2 |
glycerophosphodiester phosphodiesterase domain containing 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GDPD2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:65,826,273...65,835,361
Ensembl chr X:65,826,574...65,835,361
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GDPD3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GFPT2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
|
|
G |
Ggct |
gamma-glutamyl cyclotransferase |
decreases expression |
EXP |
Diuron results in decreased expression of GGCT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:84,122,921...84,129,327
Ensembl chr 4:84,123,118...84,129,277
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
increases expression |
EXP |
Diuron results in increased expression of GGH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
Diuron results in decreased expression of GHR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
EXP |
Diuron results in increased expression of GJA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
increases expression |
EXP ISO |
Diuron results in increased expression of GJB6 mRNA Diuron metabolite results in increased expression of GJB6 mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
NCBI chr15:31,284,562...31,295,010
Ensembl chr15:31,284,419...31,294,582
|
|
G |
Gkn1 |
gastrokine 1 |
increases expression |
EXP |
Diuron results in increased expression of GKN1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:119,790,101...119,795,389
Ensembl chr 4:119,790,101...119,795,389
|
|
G |
Gkn2 |
gastrokine 2 |
increases expression |
EXP |
Diuron results in increased expression of GKN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
|
|
G |
Glb1l2 |
galactosidase, beta 1-like 2 |
increases expression |
EXP |
Diuron results in increased expression of GLB1L2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 8:25,115,462...25,166,843
Ensembl chr 8:25,115,462...25,166,783
|
|
G |
Glce |
glucuronic acid epimerase |
increases expression |
EXP |
Diuron results in increased expression of GLCE mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:62,546,104...62,612,144
Ensembl chr 8:62,546,107...62,612,040
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
EXP |
Diuron results in increased expression of GLIPR1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Glis2 |
GLIS family zinc finger 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GLIS2 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578
|
|
G |
Glrx |
glutaredoxin |
increases expression |
EXP |
Diuron results in increased expression of GLRX mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glrx2 |
glutaredoxin 2 |
increases expression |
EXP |
Diuron results in increased expression of GLRX2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Gls |
glutaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GLS mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
increases expression |
EXP |
Diuron results in increased expression of GLUD1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
EXP |
Diuron results in decreased expression of GLUL mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gm2a |
ganglioside GM2 activator |
decreases expression |
EXP |
Diuron results in decreased expression of GM2A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
decreases expression |
EXP |
Diuron results in decreased expression of GNAI1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:16,813,941...16,898,111
Ensembl chr 4:16,814,001...16,896,417
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
decreases expression |
EXP |
Diuron results in decreased expression of GNAI3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gng11 |
G protein subunit gamma 11 |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of GNG11 mRNA Diuron results in increased expression of GNG11 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442
|
|
G |
Golph3l |
golgi phosphoprotein 3-like |
decreases expression |
EXP |
Diuron results in decreased expression of GOLPH3L mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:183,151,941...183,183,094
Ensembl chr 2:183,153,301...183,183,083
|
|
G |
Golt1a |
golgi transport 1A |
increases expression |
EXP |
Diuron results in increased expression of GOLT1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr13:44,760,356...44,773,123
Ensembl chr13:44,760,380...44,773,122
|
|
G |
Gorasp1 |
golgi reassembly stacking protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GORASP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:119,655,267...119,667,022
Ensembl chr 8:119,655,268...119,666,972
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GOT1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
increases expression |
EXP |
Diuron results in increased expression of GOT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpatch4 |
G patch domain containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of GPATCH4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
|
|
G |
Gpc3 |
glypican 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GPC3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr X:131,868,983...132,236,837
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GPD1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
EXP |
Diuron results in decreased expression of GPM6A mRNA |
CTD |
PMID:25152437 |
|
NCBI chr16:36,641,282...36,973,477
Ensembl chr16:36,641,284...36,973,475
|
|
G |
Gprasp2 |
G protein-coupled receptor associated sorting protein 2 |
decreases expression |
EXP |
Diuron results in decreased expression of GPRASP2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:98,817,669...98,823,814
Ensembl chr X:98,817,593...98,824,402
|
|
G |
Gpsm2 |
G-protein signaling modulator 2 |
increases expression |
EXP |
Diuron results in increased expression of GPSM2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases expression |
EXP |
Diuron results in decreased expression of GPT mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX3 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression |
EXP |
Diuron results in decreased expression of GPX7 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of GPX8 mRNA Diuron results in decreased expression of GPX8 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
|
|
G |
Gramd1c |
GRAM domain containing 1C |
increases expression |
EXP |
Diuron results in increased expression of GRAMD1C mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:56,633,229...56,718,570
Ensembl chr11:56,633,227...56,718,570
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
decreases expression |
EXP |
Diuron results in decreased expression of GRB10 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr14:86,495,054...86,602,815
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grhl3 |
grainyhead-like transcription factor 3 |
increases expression |
EXP |
Diuron results in increased expression of GRHL3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:147,774,160...147,806,338
Ensembl chr 5:147,774,160...147,806,160
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of GRHPR mRNA Diuron results in increased expression of GRHPR mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GRINA mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 7:107,962,194...107,965,368
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
increases expression |
EXP |
Diuron results in increased expression of GRK5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
|
|
G |
Grtp1 |
growth hormone regulated TBC protein 1 |
increases expression |
EXP |
Diuron results in increased expression of GRTP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:76,332,777...76,356,414
Ensembl chr16:76,283,103...76,354,440
|
|
G |
Gsn |
gelsolin |
decreases expression |
EXP |
Diuron results in decreased expression of GSN mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gspt2 |
G1 to S phase transition 2 |
increases expression |
EXP |
Diuron results in increased expression of GSPT2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
EXP |
Diuron results in increased expression of GSR mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression affects expression |
EXP |
Diuron results in increased expression of GSTA2 mRNA Diuron affects the expression of GSTA2 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
Diuron results in increased expression of GSTA3 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression |
EXP |
Diuron results in increased expression of GSTA4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
Diuron results in increased expression of GSTA5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GSTK1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
Diuron results in increased expression of GSTM1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
decreases expression |
EXP |
Diuron results in decreased expression of GSTM5 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GSTO1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Diuron results in increased expression of GSTP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression |
EXP |
Diuron results in increased expression of GTF2B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GUCY1A1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
EXP |
Diuron results in decreased expression of GULP1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
H1f0 |
H1.0 linker histone |
increases expression |
EXP |
Diuron results in increased expression of H1F0 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
EXP |
Diuron results in increased expression of H2AZ1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:226,355,769...226,357,878
Ensembl chr 2:226,355,708...226,358,485
|
|
G |
H3f3b |
H3.3 histone B |
increases expression |
EXP |
Diuron results in increased expression of H3F3B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:101,256,488...101,258,712
Ensembl chr10:101,256,480...101,258,709
|
|
G |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
increases expression decreases expression |
EXP |
Diuron results in increased expression of HACD1 mRNA Diuron results in decreased expression of HACD1 mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
|
|
G |
Hap1 |
huntingtin-associated protein 1 |
increases expression |
EXP |
Diuron results in increased expression of HAP1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
EXP |
Diuron results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243
|
|
G |
Has2 |
hyaluronan synthase 2 |
increases expression |
ISO |
Diuron metabolite results in increased expression of HAS2 mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HDAC2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:40,548,250...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
EXP |
Diuron results in increased expression of HES1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
decreases expression |
EXP |
Diuron results in decreased expression of HIBADH mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Diuron results in increased expression of HIGD1A mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression decreases expression |
EXP |
Diuron results in increased expression of HIST1H4B mRNA Diuron results in decreased expression of HIST1H4B mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
decreases expression |
EXP |
Diuron metabolite results in decreased expression of HIST2H2BE mRNA |
CTD |
PMID:24172598 |
|
NCBI chr 2:183,780,449...183,783,030
|
|
G |
Hk3 |
hexokinase 3 |
decreases expression |
EXP |
Diuron results in decreased expression of HK3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
EXP |
Diuron results in increased expression of HMGCS1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGN2 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
decreases expression |
EXP |
Diuron results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:25152437 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
increases expression |
EXP |
Diuron results in increased expression of HNRNPD mRNA |
CTD |
PMID:21551480 |
|
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPH1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 |
decreases expression |
EXP |
Diuron results in decreased expression of HNRNPH3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr20:25,616,400...25,625,814
Ensembl chr20:25,614,733...25,625,750
|
|
G |
Hopx |
HOP homeobox |
decreases expression increases expression |
EXP |
Diuron results in decreased expression of HOPX mRNA Diuron results in increased expression of HOPX mRNA |
CTD |
PMID:21551480 PMID:25152437 |
|
NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909
|
|
G |
Hoxa3 |
homeobox A3 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:81,269,243...81,313,218
Ensembl chr 4:81,269,243...81,313,218
|
|
G |
Hoxa5 |
homeo box A5 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA5 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hoxa9 |
homeobox A9 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXA9 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 4:81,323,235...81,329,344
Ensembl chr 4:81,323,382...81,326,358
|
|
G |
Hoxb3 |
homeo box B3 |
decreases expression |
EXP |
Diuron results in decreased expression of HOXB3 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr10:81,258,739...81,314,134
Ensembl chr10:81,299,357...81,313,107
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
decreases expression |
EXP |
Diuron results in decreased expression of HPCAL1 mRNA |
CTD |
PMID:21551480 |
|
NCBI chr 6:40,478,182...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases expression increases expression |
EXP ISO |
Diuron results in decreased expression of HPGD mRNA Diuron metabolite results in increased expression of HPGD mRNA |
CTD |
PMID:21551480 PMID:24172598 |
|
| |